​

Atara Biotherapeutics (ATRA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Atara Biotherapeutics Revenue Highlights

Latest Revenue (Y)

$128.94M

0

Atara Biotherapeutics Revenue by Period

Atara Biotherapeutics Revenue by Year

DateRevenueChange
2024-12-31$128.94M1404.02%
2023-12-31$8.57M-86.51%
2022-12-31$63.57M212.55%
2021-12-31$20.34M100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31--

Atara Biotherapeutics generated $128.94M in revenue during NA 2024, up 1404.02% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Atara Biotherapeutics Revenue by Quarter

DateRevenueChange
2025-06-30--100.00%
2025-03-31$98.15M199.66%
2024-12-31$32.75M-18.50%
2024-09-30$40.19M40.33%
2024-06-30$28.64M4.69%
2024-03-31$27.36M543.39%
2023-12-31$4.25M98.88%
2023-09-30$2.14M123.41%
2023-06-30$957.00K-21.94%
2023-03-31$1.23M454.75%
2022-12-31$221.00K-95.04%
2022-09-30$4.46M-91.36%
2022-06-30$51.58M605.21%
2022-03-31$7.31M-3.10%
2021-12-31$7.55M40.56%
2021-09-30$5.37M38.76%
2021-06-30$3.87M8.95%
2021-03-31$3.55M-99.01%
2020-12-31$358.19M100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31--

Atara Biotherapeutics generated - in revenue during Q2 2025, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Atara Biotherapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
MGNXMacroGenics$149.96M$13.19M
ATRAAtara Biotherapeutics$128.94M-
MGXMetagenomi$44.76M$8.51M
CNTBConnect Biopharma$26.03M$1.91M
SRZNSurrozen$10.65M$983.00K
SPRBSpruce Biosciences$4.91M-
ATYRaTyr Pharma$353.00K-
GUTSFractyl Health$120.00K-
ANEBAnebulo Pharmaceuticals--
QNCXQuince Therapeutics--
BMEABiomea Fusion--

ATRA Revenue FAQ

What is Atara Biotherapeutics’s yearly revenue?

Atara Biotherapeutics's yearly revenue for 2024 was $128.94M, representing an increase of 1404.02% compared to 2023. The company's yearly revenue for 2023 was $8.57M, representing a decrease of -86.51% compared to 2022. ATRA's yearly revenue for 2022 was $63.57M, representing an increase of 212.55% compared to 2021.

What is Atara Biotherapeutics’s quarterly revenue?

Atara Biotherapeutics's quarterly revenue for Q2 2025 was $0, a -100.00% decrease from the previous quarter (Q1 2025), and a -100.00% decrease year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $98.15M, a 199.66% increase from the previous quarter (Q4 2024), and a 258.77% increase year-over-year (Q1 2024). ATRA's quarterly revenue for Q4 2024 was $32.75M, a -18.50% decrease from the previous quarter (Q3 2024), and a 670.30% increase year-over-year (Q4 2023).

What is Atara Biotherapeutics’s revenue growth rate?

Atara Biotherapeutics's revenue growth rate for the last 3 years (2022-2024) was 102.82%, and for the last 5 years (2020-2024) was 0%.